66 related articles for article (PubMed ID: 29100316)
1. Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.
Najem A; Krayem M; Sabbah S; Pesetti M; Journe F; Awada A; Désaubry L; Ghanem GE
Cells; 2023 Jul; 12(14):. PubMed ID: 37508519
[TBL] [Abstract][Full Text] [Related]
2. The Prohibitin-Binding Compound Fluorizoline Activates the Integrated Stress Response through the eIF2α Kinase HRI.
Sánchez-Vera I; Núñez-Vázquez S; Saura-Esteller J; Cosialls AM; Heib J; Nadal Rodríguez P; Ghashghaei O; Lavilla R; Pons G; Gil J; Iglesias-Serret D
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175767
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
Ortiz MV; Ahmed S; Burns M; Henssen AG; Hollmann TJ; MacArthur I; Gunasekera S; Gaewsky L; Bradwin G; Ryan J; Letai A; He Y; Naranjo A; Chi YY; LaQuaglia M; Heaton T; Cifani P; Dome JS; Gadd S; Perlman E; Mullen E; Steen H; Kentsis A
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391345
[TBL] [Abstract][Full Text] [Related]
4. Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma.
MacArthur IC; Bei Y; Garcia HD; Ortiz MV; Toedling J; Klironomos F; Rolff J; Eggert A; Schulte JH; Kentsis A; Henssen AG
JCI Insight; 2019 Apr; 5(10):. PubMed ID: 30998507
[TBL] [Abstract][Full Text] [Related]
5. Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.
Yang J; Li B; He QY
Cell Death Dis; 2018 May; 9(6):580. PubMed ID: 29784973
[TBL] [Abstract][Full Text] [Related]
6. Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells.
Ma LL; Shen L; Tong GH; Tang N; Luo Y; Guo LL; Hu CT; Huang YX; Huang G; Jing FY; Liu C; Li ZY; Zhou N; Yan QW; Lei Y; Zhu SJ; Cheng ZQ; Cao GW; Deng YJ; Ding YQ
Oncotarget; 2017 Sep; 8(44):76340-76356. PubMed ID: 29100316
[TBL] [Abstract][Full Text] [Related]
7. Cdc42 subcellular relocation in response to VEGF/NRP1 engagement is associated with the poor prognosis of colorectal cancer.
Ma LL; Guo LL; Luo Y; Liu GL; Lei Y; Jing FY; Zhang YL; Tong GH; Jing ZL; Shen L; Tang MS; Ding YQ; Deng YJ
Cell Death Dis; 2020 Mar; 11(3):171. PubMed ID: 32139668
[TBL] [Abstract][Full Text] [Related]
8. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
10. PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization.
Wang P; Zhao J; Yang X; Guan S; Feng H; Han D; Lu J; Ou B; Jin R; Sun J; Zong Y; Feng B; Ma J; Lu A; Zheng M
Med Oncol; 2015 Dec; 32(12):264. PubMed ID: 26553318
[TBL] [Abstract][Full Text] [Related]
11. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
